Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Elanco Animal Health Incorporated Common Stock (ELAN) vs KLA Corp. (KLAC) Price & Performance

Elanco Animal Health Incorporated Common StockTrade

Price performance (Past 24H)

Key statistics

Elanco Animal Health Incorporated Common Stock vs KLA Corp. — how do they compare? Elanco Animal Health Incorporated Common Stock trades at $22.5 (market cap $11.17B), while KLA Corp. trades at $201.98 (market cap $256.86B). The key difference: KLA Corp. is far larger — about 23× Elanco Animal Health Incorporated Common Stock's market cap, and KLA Corp. pays a 0.47% dividend while Elanco Animal Health Incorporated Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Elanco Animal Health Incorporated Common Stock for 0 Days and KLA Corp. for 60 Days on average.

ELANKLAC
Market Cap
$11.17B$256.86B
Volume
4,196,2427,016,455
Sector
HealthTechnology
52-Week High
$26.84$301.71
52-Week Low
$19.76$98.28
Typical Hold Time
0 Days60 Days
Enterprise Value
$14.56B$258.11B
Dividend Yield
—0.47%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Elanco Animal Health Incorporated Common Stock

No Aura AI signal available yet.

KLA Corp.

KLA Corporation (KLAC) trades at $196.72, down 0.37% on the day, with a bullish technical signal from moving averages and strong fundamental performance. The company reported revenue of $12.16 billion in 2025, with net income of $4.06 billion and a robust net margin of 33.41%. Recent earnings beats and a significant backlog driven by AI demand highlight operational strength, while analyst consensus remains strongly positive with a $223.88 price target.

The outlook for KLAC is favorable, supported by AI-led growth in semiconductor equipment demand and solid financials, though high valuation multiples and competitive pressures pose risks. Upside potential exists if the company continues to exceed earnings expectations and capitalize on industry tailwinds, but investors should monitor margin trends and debt levels.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ELAN
100% Buy0% Sell
Avg holding period · 0 Days
KLAC
66% Buy34% Sell
Avg holding period · 60 Days

About Elanco Animal Health Incorporated Common Stock

Elanco develops medicines, vaccines, and other health products for pets and livestock. Its products address prevention and treatment of animal diseases.

Read more on ELAN →

About KLA Corp.

KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.

Read more on KLAC →